Fact CheckerSign in

NCT07750197Completed

Exercise and Diet Responses in Adult Men With Obesity by MC4R Genotype and Metabolic Health

Association of MC4R rs17782313 Polymorphism and Metabolic Phenotype With Responses to a 12-Week Combined Exercise and Dietary Intervention in Adult Men With Obesity

Source: ClinicalTrials.gov · Last updated 6 Aug 2026

Brief summary (registry, in English)

This study evaluated whether differences in the MC4R rs17782313 gene variant and metabolic health status were associated with different responses to a 12-week exercise and dietary intervention in adult men with obesity. A total of 40 men aged 18 to 59 years with obesity participated in the study. At baseline, participants were classified as having metabolically healthy obesity or metabolically unhealthy obesity according to metabolic risk factors. All participants received the same supervised lifestyle intervention, which included aerobic exercise, resistance training, and an individualized energy-controlled diet. Body weight, body composition, physical fitness, blood pressure, blood glucose, blood lipids, glycated hemoglobin, and fasting insulin were measured before and after the 12-week intervention. Blood samples were also collected for MC4R rs17782313 genotyping. The study examined whether changes after the intervention differed according to baseline metabolic phenotype and MC4R genotype.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
3 Aug 2026
Start date
1 Mar 2025
Primary completion date
1 Jun 2025
Lead sponsor
Harbin Sport University
Diseases
Obesity
NCT number
NCT07750197

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 1 Mar 2025 to the primary completion date, 1 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of antihypertensive medication
  • Current use of lipid-lowering medication

Other illness

  • Severe hepatic insufficiency
  • Severe renal insufficiency
  • Cardiovascular disease
  • Other clinically significant vascular disease

Lab values

  • Current use of glucose-lowering medication

Other

  • Unable or unwilling to comply with the intervention and assessment schedule

Who the study is looking for

  • Male sex
  • Age 18 to 59 years
  • Body mass index of at least 28 kg/m2
  • Waist circumference of at least 90 cm
  • Able and willing to provide written informed consent
  • Able and willing to participate in the 12-week supervised exercise and dietary intervention and complete the scheduled assessments

Age in the registry: 18 years to 59 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Harbin Sport University
Coordinator of this site? Confirm its status
HarbinChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.